ACHV - Achieve Life Sciences Inc Stock Price, Fair Value and News

$4.87+0.32 (+7.03%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ACHV Price Action

Last 7 days

0.6%

Last 30 days

-4.7%

Last 90 days

74.6%

Trailing 12 Months

6.8%

ACHV RSI Chart

ACHV Valuation

Market Cap

259.2M

Price/Earnings (Trailing)

-4.95

Price/Sales (Trailing)

49.85

EV/EBITDA

-17.1

Price/Free Cashflow

-6.37

ACHV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ACHV Fundamentals

ACHV Revenue

Revenue (TTM)

5.1M

ACHV Earnings

Earnings (TTM)

-52.3M

Earnings Growth (Yr)

-15.42%

Earnings Growth (Qtr)

-13.55%

ACHV Profitability

EBT Margin

-323.88%

Return on Equity

-155.72%

Return on Assets

-100.59%

Free Cashflow Yield

-15.69%

ACHV Investor Care

Shares Dilution (1Y)

54.80%

Diluted EPS (TTM)

-1.38

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2016	19.7M	17.8M	11.1M	5.1M
2015	16.8M	15.9M	17.8M	18.2M
2014	36.5M	35.1M	30.1M	27.1M
2013	23.9M	27.8M	31.1M	29.9M
2012	5.6M	6.2M	11.6M	20.1M
2011	10.1M	10.3M	6.6M	5.5M
2010	0	21.6M	17.6M	13.6M
2009	0	0	0	25.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

CEO	Mr. John A. Bencich M.B.A.
WEBSITE	achievelifesciences.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	20

Achieve Life Sciences Inc Frequently Asked Questions

What is the ticker symbol for Achieve Life Sciences Inc? What does ACHV stand for in stocks?

ACHV is the stock ticker symbol of Achieve Life Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Achieve Life Sciences Inc (ACHV)?

As of Wed Dec 03 2025, market cap of Achieve Life Sciences Inc is 259.25 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ACHV stock?

You can check ACHV's fair value in chart for subscribers.

Is Achieve Life Sciences Inc a good stock to buy?

The fair value guage provides a quick view whether ACHV is over valued or under valued. Whether Achieve Life Sciences Inc is cheap or expensive depends on the assumptions which impact Achieve Life Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ACHV.

What is Achieve Life Sciences Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, ACHV's PE ratio (Price to Earnings) is -4.95 and Price to Sales (PS) ratio is 49.85. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ACHV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Achieve Life Sciences Inc's stock?

In the past 10 years, Achieve Life Sciences Inc has provided -0.468 (multiply by 100 for percentage) rate of return.